Back to Journals » Drug Design, Development and Therapy » Volume 13

Clinical Trial Report

Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system

         
Total article views   Abstract views HTML views PDF downloads Totals
5,005 Dovepress* 3,919 519+ 1,020 4,438
PubMed Central* 0 567 192 567
Totals 3,919 1,086 1,212 5,005
*Since 12 March 2019
+Since July 2016

View citations on PubMed Central and Google Scholar